secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catalent, Inc. (—)
CIK:        0001596783
Form:       8-K
Filed at:   2024-12-18T23:59:59+00:00
Accession:  0001193125-24-280922
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novo Holdings completes $16.5B acquisition of Catalent at $63.50/share; stock delisted
--------------------------------------------------------------------------------

- All-cash transaction valued at ~$16.5B; shareholders receive $63.50/share, a ~47.5% premium to 60-day VWAP as of Feb 2, 2024.
- Catalent common stock suspended and delisted from NYSE; Form 15 to be filed to terminate SEC reporting obligations.
- All 12 pre-merger directors resigned; new board consists of Alessandro Maselli (CEO) and John J. Greisch.
- Catalent repaid $500M 2027 Notes, €825M 2028 Notes, $550M 2029 Notes, and $650M 2030 Notes; indentures satisfied.
- Post-closing, Novo Nordisk will acquire Catalent's three fill-finish sites in Italy, Indiana, and Belgium.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1596783/000119312524280922/0001193125-24-280922-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1596783/000119312524280922/d902883d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-280922

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer